Chia‐Tien Hsu

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Synthetic (+)‐antroquinonol exhibits dual actions against insulin resistance by triggering <scp>AMP</scp> kinase and inhibiting dipeptidyl peptidase <scp>IV</scp> activities

Chia‐Tien Hsu, Rohidas S. Sulake, P‐K Huang et al. · British Journal of Pharmacology · 2014 · 19 citations · Full text

A Fatal Case of Chlorfenapyr Poisoning and the Therapeutic Implications of Serum Chlorfenapyr and Tralopyril Levels

Ming-Jin Chung, Yan‐Chiao Mao, Chia‐Tien Hsu et al. · Medicina · 2022 · 16 citations · Full text

Bone Scintigraphy in Evaluation of Heel Pain in Reiter's Disease: Compared with Radiography and Clinical Examination

Yi-Ching Lin, S. -J. Wang, J. Lang et al. · Scandinavian Journal of Rheumatology · 1995 · 14 citations